Australian Competition and Consumer Commission v Ashley & Martin Pty Ltd (No 2)

Link copied
Case Copied 27 min read

FEDERAL COURT OF AUSTRALIA

Australian Competition and Consumer Commission v Ashley & Martin Pty Ltd (No 2) [2019] FCA 1739

File number: WAD 606 of 2017
Judge: BANKS-SMITH J
Date of judgment: 24 October 2019
Catchwords: CONSUMER LAW - relief hearing - terms of contracts unfair within meaning of s 23 and s 24 of Australian Consumer Law - whether appropriate to make declarations - whether appropriate to make non-party consumer redress order - declarations and orders made
Legislation:

Australian Securities and Investments Commission Act 2001 (Cth) s 12GNB

Competition and Consumer Act 2010 (Cth) Schedule 2 (Australian Consumer Law) ss 23, 24, 239, 240, 241, 243, 250, Chapter 2

Federal Court of Australia Act 1976 (Cth) s 21

Cases cited:

Australian Competition and Consumer Commission v AGLSouth Australia Pty Ltd [2015] FCA 399

Australian Competition and Consumer Commission v Ashley & Martin Pty Ltd [2019] FCA 1436

Australian Competition and Consumer Commission v Clinica Internationale Pty Ltd (No 2) [2016] FCA 62

Australian Competition and Consumer Commission v Reebok Australia Pty Ltd [2015] FCA 83

Australian Competition and Consumer Commission v The Construction, Forestry, Mining and Energy Union [2006] FCA 1730

Director of Consumer Affairs Victoria v Domain Register Pty Ltd (No 2) [2018] FCA 2008

Forster v Jododex Australia Pty Ltd [1972] HCA 61; (1972) 127 CLR 421

Swishette Pty Ltd v Australian Competition and Consumer Commission [2017] FCAFC 45; (2017) 249 FCR 483

Date of hearing: 22 October 2019
Registry: Western Australia
Division: General Division
National Practice Area: Commercial and Corporations
Sub-area: Regulator and Consumer Protection
Category: Catchwords
Number of paragraphs: 51
Counsel for the Applicant: Ms KR Lendich
Solicitor for the Applicant: Corrs Chambers Westgarth
Counsel for the Respondent: Mr WAS Keane
Solicitor for the Respondent: Norton Rose Fulbright

ORDERS

WAD 606 of 2017
BETWEEN:

AUSTRALIAN COMPETITION AND CONSUMER COMMISSION
Applicant

AND:

ASHLEY & MARTIN PTY LTD (ACN 090 141 021)
Respondent

JUDGE:

BANKS-SMITH J

DATE OF ORDER:

24 OCTOBER 2019

THE COURT DECLARES THAT:

1.The terms in contracts between the respondent and consumers which are marked on the Personal RealGROWTH Program contract identified with code AU PRG01.10 (First Contract) in Annexure A to these orders are unfair terms within the meaning of s 24 of the Australian Consumer Law (ACL), and are void pursuant to s 23 of the ACL, because they commit the consumer to pay for a medical treatment program before the consumer has had the opportunity to receive and consider medical advice and give or refuse informed consent to the medical treatment.

2.The terms in contracts between the respondent and consumers which are marked on the Personal RealGROWTH Program contract identified with code AU PRG09.16 (Second Contract) in Annexure B to these orders are unfair terms within the meaning of s 24 of the ACL, and are void pursuant to s 23 of the ACL, because they commit the consumer to pay for a medical treatment program before the consumer has…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Australian Competition and Consumer Commission v Ashley & Ma... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2019] FCA 1739
Decision Date

CaseChat Overview and Summary

In the case of Australian Competition and Consumer Commission v Ashley & Martin Pty Ltd (No 2), the Australian Competition and Consumer Commission (ACCC) sought relief for consumers who had entered into contracts with Ashley & Martin Pty Ltd for medical treatment programs. The ACCC alleged that the contracts contained unfair terms under the Australian Consumer Law (ACL) and sought declaratory relief, consumer redress orders, and costs. The Federal Court of Australia was tasked with deciding whether the impugned terms of the contracts were indeed unfair and, if so, whether the proposed relief was appropriate.

The court was required to determine if the terms of the contracts were unfair within the meaning of section 24 of the ACL and if it was appropriate to declare these terms void under section 23 of the ACL. Additionally, the court had to consider whether it was appropriate to make non-party consumer redress orders under section 239 of the ACL. The primary legal issues centred around the interpretation of the ACL provisions concerning unfair contract terms and the court's discretion in making declarations and consumer redress orders.

The court found that the terms of the contracts were indeed unfair as they committed consumers to pay for a medical treatment program before they had the opportunity to receive and consider medical advice and give or refuse informed consent. The court exercised its discretion under section 21 of the Federal Court of Australia Act 1976 and section 250 of the ACL to make the proposed declarations. The court also found that a consumer redress regime was appropriate to provide redress to non-party consumers. The court made orders for Ashley & Martin Pty Ltd to review its records, offer refunds to relevant patients, and pay the refund amounts to patients who accepted the offer within the specified timeframe.

In summary, the court granted the ACCC's application for declaratory relief and consumer redress orders. The declarations confirmed that the impugned terms of the contracts were unfair and void, and the consumer redress orders mandated that Ashley & Martin Pty Ltd review its records, offer refunds to eligible patients, and pay refunds to those who accepted the offer within 90 days. Ashley & Martin Pty Ltd was also ordered to pay the ACCC's costs.

Orders

Orders of the court

4. By way of redress to non-party consumers under s 239 of the ACL:

(a) within 90 days of the date of this order, the respondent will conduct a review of its records (including its Enterprise Resource Management system, emails and point of sale records) to identify who of its patients belong to a class of the Relevant Patients, as defined below;

(b) within 21 days of completing the review referred to in (a) above, the respondent will send a letter to the effect of the letter that is Annexure D to each Relevant Patient at the email and postal addresses last known to the respondent to offer a refund (Refund Offer) of the Refund Amount, as defined below;

(c) if no response is received by the respondent from the Relevant Patient within 60 days of the respondent sending the communication referred to in (b) above, the respondent will again write to each Relevant Patient notifying the Relevant Patient that if no response is received within 30 days, then no refund will be payable; and

(d) to each Relevant Patient who accepts a Refund Offer within 90 days of the Refund Offer being sent, the respondent will pay the relevant Refund Amount within a further 7 days.

5. For the purpose of order 4, and subject to the exclusions in order 6, the Relevant Patients are persons who:

(a) signed either the First Contract, Second Contract or Third Contract (Relevant Contract):

(i) prior to receiving medical advice in relation to a Medical Treatment Program (as defined in the Relevant Contract); or

(ii) within a period of 7 days after receiving medical advice in relation to a Medical Treatment Program (as defined in the Relevant Contract); and

(b) during the term of the Relevant Contract:

(i) were advised by a medical practitioner (contracted by the respondent or otherwise) that the Medical Treatment Program was not suitable (Category A); or

(ii) experienced one or more side-effects from the medically prescribed drugs used in the Medical Treatment Program that caused them to stop using that drug (Category B); or

(iii) within 7 days of signing the Relevant Contract or first receiving medical advice in relation to a Medical Treatment Program (whichever is later), expressed to the respondent a wish to terminate the Relevant Contract or obtain a refund under it (Category C); or

(iv) expressed to the respondent a wish to terminate the Relevant Contract or obtain a refund under it because the patient:

(A) had not had the opportunity to receive and/or consider medical advice; or

(B) had subsequently received and considered medical advice and no longer wished to undertake their Medical Treatment Program (Category D).

6. Relevant Patients excludes those who:

(a) (in respect of Categories A and B only) continued under an amended medical treatment program which contained one of the medically prescribed drugs, unless the patient falls within Category C or D in which case they will receive a full refund; or

(b) prior to signing the Relevant Contract, had been prescribed and used the same medically prescribed drugs that were supplied pursuant to the Relevant Contract pursuant to a previous contract or treatment program; or

(c) after the term of the Relevant Contract, had undertaken a subsequent Medical Treatment Program containing the same medically prescribed drugs that were supplied pursuant to the Relevant Contract.

7. For the purpose of order 4, the Refund Amount is:

(a) a full refund of all money paid under the Relevant Contract;

(b) less any amount already refunded to the Relevant Patient.

8. The respondent pay the applicant's costs, to be taxed if not agreed.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Annexure A

Annexure B

Annexure C

Annexure D

Dear [Patient]

Ashley & Martin Pty Ltd - Entitlement to refund

Our records say that you entered into a Personal RealGROWTH Program contract between June 2014 and June 2017.

The Federal Court of Australia has found that during that period Ashley & Martin's Personal RealGROWTH Program contracts contained unfair contract terms. The reasons for that are set out in a Judgment that can be found at:

https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2019/2019fca1436.

The Court has ordered Ashley & Martin refund the amounts you paid to us [where appropriate: less the refund you have already received by an earlier refund].

If you would like to claim your refund, please contact us no later than [Date of letter +90 days] either by:

• telephone at [insert number];

• email at [insert address]; or

• post addressed to:

The Proper Officer

Ashley & Martin Pty Ltd

673 Murray St

WEST PERTH WA 6005

If you do not contact us by [Date of letter +90 days], you will lose your entitlement to a refund through this process.

If you elect to receive a refund through this process you will not be able to claim those amounts in separate proceedings by you (as an individual) against Ashley & Martin.

If you have any questions about this, please contact [name] at [number].

Yours sincerely

Ashley & Martin Pty Ltd

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established

The parties propose that first, the court make declarations under s 21 of the Federal Court of Australia Act 1976 (Cth) and s 250 of the ACL. Second, it is proposed that there be a consumer redress regime in accordance with s 239 of the ACL.Declarations Ashley & Martin accepted prior to the liability hearing that if the Court were to find that the impugned terms of the contracts were unfair, then declaratory relief was appropriate. It has properly maintained that position. The parties have agreed that there be declarations with respect to each of the contracts to the following effect:(1)The terms of the contracts identified with code AU PRG01.10 (First Contract) in Annexure A to these orders are unfair terms within the meaning of s 24 of the ACL, and are void pursuant to s 23 of the ACL, because they commit the consumer to pay for a medical treatment program before the consumer has had the opportunity to receive and consider medical advice and give or refuse informed consent to the medical treatment.(2)The terms in contracts between the respondent and consumers which are marked on the Personal RealGROWTH Program contract identified with code AU PRG09.16 (Second Contract) in Annexure B to these orders are unfair terms within the meaning of s 24 of the ACL, and are void pursuant to s 23 of the ACL, because they commit the consumer to pay for a medical treatment program before the consumer has had the opportunity to receive and consider medical advice and give or refuse informed consent to the medical treatment.(3)The terms in contracts between the respondent and consumers which are marked on the Personal RealGROWTH Program contract identified with code AU PRG12.16 (Third Contract) and otherwise in Annexure C to these orders are unfair terms within the meaning of s 24 of the ACL, and are void pursuant to s 23 of the ACL, because they commit the consumer to pay for a medical treatment program before the consumer has had the opportunity to receive and consider medical advice and give or refuse informed consent to the medical treatment. The Court has a wide discretionary power to make declarations under s 21 of the Federal Court Act. As established in Forster v Jododex Australia Pty Ltd [1972] HCA 61; (1972) 127 CLR 421 at 437‑438, the following three threshold requirements should be satisfied before a declaration will be made:(a)the question must be a real and not a hypothetical or theoretical one;(b)the applicant must have a real interest in raising it; and(c)there must be a proper contradictor. Each of these requirements is satisfied in this case:(a)the proposed declarations relate to clauses within Ashley & Martin's standard form contracts which are void on the basis that they have been found to be unfair terms within the meaning of s 23 and s 24 of the ACL, and the matters in issue have been identified and particularised by the parties with precision;(b)it is in the public interest for the Australian Competition and Consumer Commission (ACCC) to seek to have the declarations made, and for the declarations to be made, as:(i)there is a significant legal controversy in this case, which is to be resolved;(ii)declaratory orders of the kind proposed are in the public interest because they make it plain that the relevant clauses of the standard form contracts are unfair terms; and(iii)the ACCC is the public regulator under the Competition and Consumer Act2010 (Cth) (CCA) and in this role it has a genuine interest in seeking the declaratory relief and having that relief granted by this Court; and(c)Ashley & Martin is a proper contradictor because, notwithstanding it now consents to the declaratory relief, as is apparent from the liability hearing, it had a genuine interest in resisting the granting of the declarations.